CVS Health is in the advanced stages of a $66 billion deal to buy health insurance giant Aetna, according to a report.
The Wall Street Journal reported Thursday that the deal could be announced as early as Monday, but that it also was still possible it might fall apart.
The report said the deal would likely be valued at between $200 and $205 per Aetna share.
Neither CVS Health nor Aetna would confirm the report to the Washington Examiner.
“As a matter of policy we never comment on rumors or speculation,” said David Palombi, spokesman for CVS Health.
Aetna had a similar response.
“We don’t comment on rumors or speculation,” said T.J. Crawford, Aetna spokesman.
A purchase by CVS Health would allow Aetna to have its own pharmacy benefits manager, as one of its competitors, UnitedHealthcare, already does.
Another large merger valued at $37 billion for Aetna, with fellow insurance provider Humana, was blocked by a federal judge who cited antitrust issues.
